My research has had significant impact on our knowledge of the biology and genomics and drug response of leukaemia (ALL and CML). My ongoing engagement with Pharma, means I can influence research and translational strategies in Industry. In my role as ALL Flagship lead, I direct ALL genomic and other screening strategies at the national level, and work with the health economics/policy teams to drive genomics into the clinical space. In my role on the Australian Genomics Executive I advise on new research/translation strategies across all Flagships. I am an invited member, and scientific advisor to the ANZCHOG Leukaemia committee and of the ALLG research committee, where I am also the Australian mRNA Seq lead. I am actively engaged in clinical trial design and head the correlative science component for current ALL clinical trials across the age course.